ArticleInternational journal of cancer2017

Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.

Shinichi Esaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.